tiprankstipranks
Eurocine Vaccines AB (DE:8X4)
FRANKFURT:8X4
Germany Market

Eurocine Vaccines AB (8X4) Financial Statements

0 Followers

Eurocine Vaccines AB Financial Overview

Eurocine Vaccines AB's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Eurocine Vaccines AB is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit-----
EBITkr -5.64Mkr -5.29Mkr -3.98Mkr -6.06Mkr -4.60M
EBITDAkr -5.64Mkr -5.29Mkr -3.98Mkr -6.06Mkr -4.60M
Net Income Common Stockholderskr -5.64Mkr -5.29Mkr -3.98Mkr -6.06Mkr -4.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 15.51Mkr 20.72Mkr 25.65Mkr 13.86Mkr 19.73M
Total Assetskr 20.10Mkr 25.35Mkr 30.14Mkr 35.76Mkr 20.24M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -15.51Mkr -20.72Mkr -25.65Mkr -13.86Mkr -19.73M
Total Liabilitieskr 3.20Mkr 2.79Mkr 2.24Mkr 3.85Mkr 2.33M
Stockholders Equitykr 16.90Mkr 22.57Mkr 27.91Mkr 31.91Mkr 17.91M
Cash Flow-
Free Cash Flowkr -5.18Mkr -4.93Mkr 11.81Mkr -25.93Mkr -4.61M
Operating Cash Flowkr -5.18Mkr -4.93Mkr 11.81Mkr -25.93Mkr -4.61M
Investing Cash Flow-----
Financing Cash Flowkr -24.00Kkr 0.00kr -22.00Kkr 20.06Mkr 0.00
Currency in SEK

Eurocine Vaccines AB Earnings and Revenue History

Eurocine Vaccines AB Debt to Assets

Eurocine Vaccines AB Cash Flow

Eurocine Vaccines AB Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis